Business Description
IPI Legacy Liquidation Co
NAICS : 541714
SIC : 2834
ISIN : US45258K1097
Description
IPI Legacy Liquidation Co formerly Impel Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system. The company is developing an approach to drug delivery that administers specific formulations of drugs deep into the vascular-rich upper nasal space, a gateway for therapeutic administration of a versatile range of molecules and formulations.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.93 | |||||
| 9-Day RSI | 53.41 | |||||
| 14-Day RSI | 49.98 | |||||
| 6-1 Month Momentum % | -98.2 | |||||
| 12-1 Month Momentum % | -99.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -390.6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:IMPLQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
IPI Legacy Liquidation Co Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 20.987 | ||
| EPS (TTM) ($) | -3.13 | ||
| Beta | 0 | ||
| Volatility % | 173.13 | ||
| 14-Day RSI | 49.98 | ||
| 14-Day ATR ($) | 0.007604 | ||
| 20-Day SMA ($) | 0.010727 | ||
| 12-1 Month Momentum % | -99.4 | ||
| 52-Week Range ($) | 0.007 - 2.87 | ||
| Shares Outstanding (Mil) | 23.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
IPI Legacy Liquidation Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
IPI Legacy Liquidation Co Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
IPI Legacy Liquidation Co Frequently Asked Questions
What is IPI Legacy Liquidation Co(IMPLQ)'s stock price today?
The current price of IMPLQ is $0.02. The 52 week high of IMPLQ is $2.87 and 52 week low is $0.01.
When is next earnings date of IPI Legacy Liquidation Co(IMPLQ)?
The next earnings date of IPI Legacy Liquidation Co(IMPLQ) is 0.
Does IPI Legacy Liquidation Co(IMPLQ) pay dividends? If so, how much?
IPI Legacy Liquidation Co(IMPLQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers